134 related articles for article (PubMed ID: 33189625)
1. Importance of the triglyceride level in identifying patients with a Type III Hyperlipoproteinemia phenotype using the ApoB algorithm.
Varghese B; Park J; Chew E; Sajja A; Brownstein A; Pallazola VA; Sathiyakumar V; Jones SR; Sniderman AD; Martin SS
J Clin Lipidol; 2021; 15(1):104-115.e9. PubMed ID: 33189625
[TBL] [Abstract][Full Text] [Related]
2. Modern prevalence of dysbetalipoproteinemia (Fredrickson-Levy-Lees type III hyperlipoproteinemia).
Pallazola VA; Sathiyakumar V; Park J; Vakil RM; Toth PP; Lazo-Elizondo M; Brown E; Quispe R; Guallar E; Banach M; Blumenthal RS; Jones SR; Marais D; Soffer D; Sniderman AD; Martin SS
Arch Med Sci; 2020; 16(5):993-1003. PubMed ID: 32863987
[TBL] [Abstract][Full Text] [Related]
3. Identification of Dysbetalipoproteinemia by an Enhanced Sampson-NIH Equation for Very Low-Density Lipoprotein-Cholesterol.
Sampson M; Wolska A; Meeusen JW; Donato LJ; Jaffe AS; Remaley AT
Front Genet; 2022; 13():935257. PubMed ID: 35910208
[TBL] [Abstract][Full Text] [Related]
4. The spectrum of type III hyperlipoproteinemia.
Sniderman AD; de Graaf J; Thanassoulis G; Tremblay AJ; Martin SS; Couture P
J Clin Lipidol; 2018; 12(6):1383-1389. PubMed ID: 30318453
[TBL] [Abstract][Full Text] [Related]
5. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
6. Hypertriglyceridemia in pregnancy does not contribute to the enhanced formation of remnant lipoprotein particles.
Okazaki M; Usui S; Tokunaga K; Nakajima Y; Takeichi S; Nakano T; Nakajima K
Clin Chim Acta; 2004 Jan; 339(1-2):169-81. PubMed ID: 14687907
[TBL] [Abstract][Full Text] [Related]
7. Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in RLP-cholesterol profiles by HPLC.
Okazaki M; Usui S; Tada N; Nakano T; Nakajima K
Clin Chim Acta; 2000 Jun; 296(1-2):135-49. PubMed ID: 10807977
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic.
Rioja J; Ariza MJ; García-Casares N; Coca-Prieto I; Arrobas T; Muñiz-Grijalvo O; Mangas A; Ibarretxe D; Sánchez-Chaparro MÁ; Valdivielso P
Eur J Clin Invest; 2020 Dec; 50(12):e13345. PubMed ID: 32649781
[TBL] [Abstract][Full Text] [Related]
9. Triglyceride-rich lipoproteins in chronic kidney disease patients undergoing maintenance haemodialysis treatment.
Homma K; Homma Y; Yamaguchi S; Shiina Y; Wakino S; Hayashi K; Hori S; Itoh H
Int J Clin Pract; 2012 Apr; 66(4):394-8. PubMed ID: 22420498
[TBL] [Abstract][Full Text] [Related]
10. Serum remnant lipoprotein cholesterol/triglyceride ratio as an index for screening familial type III hyperlipidaemia.
Nakajima K; Daimon M; Kamiyama K; Takanashi K; Suzuki Y; Watanabe M; Kubono K; Saniabadi AR; Takashima S; Sakurabayashi I
Ann Clin Biochem; 2007 Jul; 44(Pt 4):353-9. PubMed ID: 17663088
[TBL] [Abstract][Full Text] [Related]
11. Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle fraction of human blood plasma.
Campos E; Kotite L; Blanche P; Mitsugi Y; Frost PH; Masharani U; Krauss RM; Havel RJ
J Lipid Res; 2002 Mar; 43(3):365-74. PubMed ID: 11893772
[TBL] [Abstract][Full Text] [Related]
12. Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state.
Marcoux C; Hopkins PN; Wang T; Leary ET; Nakajima K; Davignon J; Cohn JS
J Lipid Res; 2000 Sep; 41(9):1428-36. PubMed ID: 10974050
[TBL] [Abstract][Full Text] [Related]
13. Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects.
Marcoux C; Tremblay M; Fredenrich A; Jacques H; Krimbou L; Nakajima K; Davignon J; Cohn JS
Atherosclerosis; 1998 Jul; 139(1):161-71. PubMed ID: 9699904
[TBL] [Abstract][Full Text] [Related]
14. Ratio of remnant-like particle-cholesterol to serum total triglycerides is an effective alternative to ultracentrifugal and electrophoretic methods in the diagnosis of familial type III hyperlipoproteinemia.
Wang T; Nakajima K; Leary ET; Warnick GR; Cohn JS; Hopkins PN; Wu LL; Cilla DD; Zhong J; Havel RJ
Clin Chem; 1999 Nov; 45(11):1981-7. PubMed ID: 10545069
[TBL] [Abstract][Full Text] [Related]
15. The characteristics of remnant lipoproteins in the fasting and postprandial plasma.
Nakajima K; Nakano T; Tokita Y; Nagamine T; Yatsuzuka S; Shimomura Y; Tanaka A; Sumino H; Nara M; Machida T; Murakami M
Clin Chim Acta; 2012 Jul; 413(13-14):1077-86. PubMed ID: 22433787
[TBL] [Abstract][Full Text] [Related]
16. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.
Watanabe N; Taniguchi T; Taketoh H; Kitagawa Y; Namura H; Yoneda N; Kurimoto Y; Yamada S; Ishikawa Y
Diabetes Care; 1999 Jan; 22(1):152-6. PubMed ID: 10333918
[TBL] [Abstract][Full Text] [Related]
17. A case of moderate hypertriglyceridemia with apolipoprotein E phenotype E4/3.
Kojima S; Homma Y; Sakane H; Kobayashi T; Ozawa H; Okajima Y
Tokai J Exp Clin Med; 1996 Dec; 21(4-6):165-9. PubMed ID: 9300976
[TBL] [Abstract][Full Text] [Related]
18. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
[TBL] [Abstract][Full Text] [Related]
19. Fasting remnant lipoproteins can predict postprandial hyperlipidemia.
Nagata T; Sugiyama D; Kise T; Tsuji S; Ohira H; Sato I; Yamamoto M; Kohsaka H; Kawano S; Yamashita S; Ishikawa Y; Fujioka Y
Lipids Health Dis; 2012 Oct; 11():146. PubMed ID: 23110373
[TBL] [Abstract][Full Text] [Related]
20. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study.
Quispe R; Manalac RJ; Faridi KF; Blaha MJ; Toth PP; Kulkarni KR; Nasir K; Virani SS; Banach M; Blumenthal RS; Martin SS; Jones SR
Atherosclerosis; 2015 Sep; 242(1):243-50. PubMed ID: 26232164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
